UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000047591
Receipt No. R000054272
Scientific Title Efficacy and safety of acupuncture on anorexia and dietary intake loss in patients with chronic respiratory disease (randomized controlled trial)
Date of disclosure of the study information 2022/04/26
Last modified on 2022/04/26 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of Acupuncture Therapy on Anorexia in Chronic Pulmonary diseases
Acronym EAT-ACUP trial
Scientific Title Efficacy and safety of acupuncture on anorexia and dietary intake loss in patients with chronic respiratory disease (randomized controlled trial)
Scientific Title:Acronym Effects of acupuncture on anorexia in Chronic respiratory disease (RCT)

Region
Japan

Condition
Condition Chronic respiratory disease
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To estimate the efficacy and safety of acupuncture to improve anorexia and dietary intake loss, and to maintain body weight among patients with chronic respiratory diseases
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes VAS score for appetite
Key secondary outcomes 1) Food intake
2) Body Mass Index
3) nutrition status (Alb, Pre-Alb, retinol-binding protein)
4) 24-hour heart rate variability

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Acupuncture group (group that adds acupuncture to standard treatment)
Twice a week for 5 weeks
Interventions/Control_2 Control group (normal treatment group)
5 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria 1) Patients with chronic respiratory disease who have very low food intake due to loss of appetite
2) Patients with weight loss (5% or more / 6 months) or low BMI (<20 kg / m2)
3) Patients who consented in writing
4) Patients who the doctor has determined to be stable.
Key exclusion criteria 1) Patients with malignant tumors
2) Patients with serious heart disease
3) Patients with severe liver dysfunction
4) Patients with severe renal dysfunction
5) Patients with severe asthma factors
6) Patients with collagen disease (RA, PM / DM, etc.)
7) Patients who have undergone drug changes during clinical trials
8) Patients who have already received acupuncture
9) Patient judged as inappropriate by the researchers
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Hiroshi
Middle name
Last name Kida
Organization National Hospital Organization Osaka Toneyama Medical Center
Division name Department of Respiratory Medicine
Zip code 560-8552
Address 5-1-1 Toneyama, Toyonaka, Osaka
TEL +81668532001
Email kida.hiroshi.sv@mail.hosp.go.jp

Public contact
Name of contact person
1st name Tomonori
Middle name
Last name Maekura
Organization National Hospital Organization Osaka Toneyama Medical Center
Division name Respiratory Science Laboratory
Zip code 560-8552
Address 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan
TEL +81668532001
Homepage URL
Email maekura.acupuncture@gmail.com

Sponsor
Institute National Hospital Organization Osaka Toneyama Medical Center
Institute
Department

Funding Source
Organization Grant-in-Aid for Clinical Research from National Hospital Organization in Japan
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Hospital Organization Osaka Toneyama Medical Center
Address 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan
Tel +81668532001
Email 410-chiken@mail.hosp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 04 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2022 Year 04 Month 15 Day
Date of IRB
2022 Year 04 Month 18 Day
Anticipated trial start date
2022 Year 04 Month 26 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 04 Month 26 Day
Last modified on
2022 Year 04 Month 26 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054272